RxReasoner presents a comprehensive list of pharmaceutical treatment indications drawn from medicine package inserts issued by authoritative regulatory bodies globally.
This index serves as a valuable tool to quickly access information on the recommended therapeutic approaches for different medical conditions, diseases or symptoms.
Select a letter from the index list.
Indication | Treatments |
---|---|
Decompensated cardiac failure |
Dobutamine
: Cardiac decompensation, disturbed ventricular function
–
only
minors (0 - 18 years old)
Dobutamine
: Cardiac decompensation, disturbed ventricular function
–
only
adults (18 years old or older)
|
Decompensated chronic heart failure |
Levosimendan
: Acutely decompensated chronic heart failure (ADHF)
–
only
adults (18 years old or older)
|
Decreased carbohydrate |
Glucose
: Carbohydrate depletion, fluid depletion
–
only
minors (0 - 18 years old)
, adults (18 years old or older)
|
Deep mycosis | |
Deep venous thrombosis |
Dabigatran
: Recurrent deep vein thrombosis and pulmonary embolism
–
only
adults (18 years old or older)
Enoxaparin
: Deep vein thrombosis (DVT), pulmonary embolism (PE)
–
only
adults (18 years old or older)
Heparin
: Deep vein thrombosis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Rivaroxaban
: Deep vein thrombosis (DVT), pulmonary embolism (PE)
–
only
adults (18 years old or older)
|
Deficiency of mevalonate kinase |
Canacinumab
: Hyperimmunoglobulin D syndrome (HIDS), mevalonate kinase deficiency (MKD)
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Deficiency of phosphoenolpyruvate kinase | |
Deficiency of tryptophan decarboxylase |
Eladocagene exuparvovec
: Aromatic L-amino acid decarboxylase (AADC) deficiency with a severe phenotype
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Delayed puberty | |
Deliberate self-harm | |
Delirium | |
Delta-4-3-oxosteroid-5-beta-reductase deficiency | |
Dementia associated with Parkinson's Disease |
Rivastigmine
: Mild to moderately severe dementia with idiopathic Parkinson's disease
–
only
adults (18 years old or older)
|
Demodectic blepharitis | |
Dental surgical procedure |
Hexetidine
: Mouth infections, gingivitis, sore throat, aphthous ulcer, halitosis, dental surgery
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Depressive disorder | |
Dermabrasion |
Dexpanthenol
: Superficial skin lesion, skin inflammation
|
Dermal mycosis |
Clotrimazole
: Dermal mycosis
|
Dermatitis herpetiformis |
Dapsone
: Dermatitis herpetiformis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dermatofibrosarcoma protuberans | |
Dermatographic urticaria |
Dexchlorpheniramine
: Perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, urticaria, angioedema
|
Dermatomyositis |
Azathioprine
: Auto-immune disorders
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Methylprednisolone
: Dermatomyositis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Prednisolone
: Dermatomyositis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dermatophytosis |
Econazole
: Dermatophytosis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Miconazole
: Mycotic infections of the skin and nails
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dermatosis of scalp |
Clobetasol propionate
: Recalcitrant dermatoses
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Diabetes insipidus |
Chlortalidone
: Diabetes insipidus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Hydrochlorothiazide
: Diabetes insipidus
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Diabetes mellitus |
Insulin (human)
: Diabetes mellitus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Insulin aspart
: Diabetes mellitus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Insulin detemir
: Diabetes mellitus
– men,
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Insulin glargine
: Diabetes mellitus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 - 65 years old)
Insulin glulisine
: Diabetes mellitus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Diabetes mellitus type 2 in obese | |
Diabetes mellitus type I |
Insulin degludec
: Diabetes mellitus type 2
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Teplizumab
: Delay of the Stage 3 onset of type 1 diabetes
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Diabetes mellitus type II |
Dapagliflozin
: Diabetes mellitus type 2
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Insulin degludec
: Diabetes mellitus type 2
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Liraglutide
: Diabetes mellitus type 2
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Metformin
: Type 2 diabetes mellitus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Tirzepatide
: Insufficiently controlled type 2 diabetes mellitus
–
only
adults (18 years old or older)
|
Diabetic macular edema |
Aflibercept
: Visual impairment due to diabetic macular oedema (DME)
–
only
adults (18 years old or older)
Brolucizumab
: Visual impairment due to diabetic macular oedema
–
only
adults (18 years old or older)
Faricimab
: Visual impairment due to diabetic macular oedema (DME)
–
only
adults (18 years old or older)
|
Diabetic peripheral neuropathy | |
Diaper rash |
Clobetasone
: Atopic dermatitis, irritant or allergic contact dermatitis, seborrhoeic dermatitis, nappy rash, photodermatitis
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Hydrocortisone
: Prurigo nodularis, neurodermatoses, otitis externa, intertrigo, napkin rash
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Diarrhea | |
Diffuse malignant lymphoma - histiocytic |
Axicabtagene ciloleucel
: Diffuse large B-cell lymphoma (DLBCL)
–
only
adults (18 years old or older)
Axicabtagene ciloleucel
: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
–
only
adults (18 years old or older)
Epcoritamab
: Relapsed or refractory diffuse large B-cell lymphoma
–
only
adults (18 years old or older)
Glofitamab
: Relapsed or refractory diffuse large B-cell lymphoma
–
only
adults (18 years old or older)
Lisocabtagene maraleucel
: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
–
only
adults (18 years old or older)
Loncastuximab tesirine
: Diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma (HGBL)
–
only
adults (18 years old or older)
Odronextamab
: Relapsed or refractory diffuse large B-cell lymphoma
–
only
adults (18 years old or older)
Rituximab
: Diffuse large B cell non-Hodgkin's lymphoma, CD20 positive
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Tisagenlecleucel
: Relapsed or refractory diffuse large B-cell lymphoma
–
only
adults (18 years old or older)
|
Diffuse spasm of esophagus |
Butylscopolamine
: Spasm, endoscopy of the genito-urinary tract or gastro- intestinal tract, Irritable Bowel Syndrome
–
only
children (1 year - 12 years old)
Butylscopolamine
: Spasm, endoscopy of the genito-urinary tract or gastro- intestinal tract, Irritable Bowel Syndrome
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dilation of cervical canal |
Mifepristone
: Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester
– women,
only
adults (18 - 65 years old)
|
Diphtheria caused by Corynebacterium diphtheriae |
Benzylpenicillin
: Diphtheria
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
Benzylpenicillin
: Diphtheria
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Direct current atrial defibrillation |
Sotalol
: Maintenance of normal sinus rhythm following conversion of atrial fibrillation or atrial flutter
–
only
adults (18 years old or older)
|
Discoid lupus erythematosus |
Betamethasone
: Discoid lupus erythematosus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Fluocinonide
: Discoid lupus erythematosus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Hydroxychloroquine
: Juvenile idiopathic arthritis, discoid and systemic lupus erythematosus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Hydroxychloroquine
: Rheumatoid arthritis, discoid and systemic lupus erythematosus, sunlight damaged skin
–
only
adults (18 years old or older)
|
Disease caused by 2019 novel coronavirus |
Molnupiravir
: Mild to moderate coronavirus disease 2019 (COVID-19)
–
only
adults (18 - 65 years old)
Remdesivir
: COVID-19 infection with an increased risk of progressing to severe COVID-19
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Sotrovimab
: Coronavirus disease 2019 (COVID-19) who do not require oxygen supplementation
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disease caused by Ancylostomatoidea |
Mebendazole
: Whipworm, pinworm, threadworm, roundworm, common hookworm, American hookworm
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disease caused by Gram-positive bacteria |
Floxacillin
: Infections
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disinfection of skin |
Ethanol
: Disinfection of skin
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disorder of musculoskeletal system | |
Disorder of the urea cycle metabolism |
Glycerol phenylbutyrate
: Urea cycle disorders (UCDs)
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 - 65 years old)
Sodium phenylbutyrate
: Urea cycle disorders
–
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
Sodium phenylbutyrate
: Urea cycle disorders
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 - 65 years old)
|
Disorders of skin induced by physical agents |
Dexpanthenol
: Superficial skin lesion, skin inflammation
|
Dissection of aorta |
Nicardipine
: Malignant hypertension, hypertensive encephalopathy, dissection of aorta, postoperative hypertension
–
only
elderly (65 years old or older)
Nicardipine
: Malignant hypertension, hypertensive encephalopathy, dissection of aorta, severe pre-eclampsia, postoperative hypertension
–
only
adults (18 - 65 years old)
|
Disseminated candidiasis |
Caspofungin
: Invasive candidiasis
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Fluconazole
: Invasive candidiasis
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
Fluconazole
: Invasive candidiasis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Micafungin
: Invasive candidiasis
–
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
Micafungin
: Invasive candidiasis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Voriconazole
: Invasive Candida infection
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disseminated Lyme borreliosis |
Ceftriaxone
: Disseminated Lyme borreliosis (early [Stage II] and late [Stage III])
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
Ceftriaxone
: Disseminated Lyme borreliosis (early [Stage II] and late [Stage III])
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Disseminated tuberculosis |
Methylprednisolone
: Disseminated tuberculosis
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
Diverticular disease |
Atropine
: Diverticular disease
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Doppler ultrasonography | |
Doppler ultrasonography of blood vessel | |
Drug induced gastric ulcer |
Esomeprazole
: NSAID associated benign gastric and duodenal ulcers
–
only
adults (18 years old or older)
Lansoprazole
: NSAID associated benign gastric and duodenal ulcers
–
only
adults (18 years old or older)
Omeprazole
: Non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
–
only
adults (18 years old or older)
Ranitidine
: Ulcers following NSAID therapy or associated with continued NSAIDs
–
only
adults (18 years old or older)
|
Drug reaction |
Promethazine
: Allergic rhinitis, urticaria, anaphylactic reactions to drugs
–
only
children (1 year - 12 years old)
Promethazine
: Allergic rhinitis, urticaria, anaphylactic reactions to drugs
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Drug treatment to delay menstruation | |
Drug-aggravated angio-oedema-urticaria |
Acetazolamide
: Congestive heart failure oedema, drug induced oedema
–
only
adults (18 years old or older)
|
Drug-induced hyperprolactinaemia | |
Drug-induced methemoglobinemia |
Methylthioninium chloride
: Drug induced methaemoglobinaemia
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Drug-induced peptic ulcer | |
Dry cornea |
Hypromellose
: Dehydration of the cornea and conjunctiva
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dry cough |
Dihydrocodeine
: Non-productive cough
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Diphenhydramine
: Non-productive cough
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Dry eyes |
Acetylcysteine
: Dry eyes
Carmellose
: Dry eye
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Hypromellose
: Dehydration of the cornea and conjunctiva
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Polyvidone
: Dry eye
|
Dry skin | |
Duchenne muscular dystrophy |
Ataluren
: Duchenne muscular dystrophy
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Givinostat
: Duchenne muscular dystrophy
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 - 65 years old)
Vamorolone
: Duchenne muscular dystrophy
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Duodenal ulcer caused by Helicobacter pylori |
Ranitidine
: Duodenal ulcers associated with Helicobacter pylori infection
–
only
adults (18 years old or older)
|
Duodenal ulcer caused by non-steroidal anti-inflammatory drug |
Esomeprazole
: NSAID associated benign gastric and duodenal ulcers
–
only
adults (18 years old or older)
Lansoprazole
: NSAID associated benign gastric and duodenal ulcers
–
only
adults (18 years old or older)
Omeprazole
: Non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
–
only
adults (18 years old or older)
|
Duodenal ulcer disease |
Cimetidine
: Duodenal ulceration, gastric ulceration
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Rabeprazole
: Active duodenal ulcer, active benign gastric ulcer
–
only
adults (18 years old or older)
Ranitidine
: Duodenal ulcer, benign gastric ulcer
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Sucralfate
: Duodenal ulcer, chronic gastritis, peptic esophagitis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Tripotassium dicitrato bismuthate
: Gastric ulcer, duodenal ulcer
–
only
adults (18 years old or older)
|
Dupuytren's disease of palm | |
Dyslipidemia |
Alirocumab
: Primary heterozygous familial hypercholesterolaemia, primary non-familial hypercholesterolaemia, mixed dyslipidaemia
–
only
adults (18 years old or older)
Evolocumab
: Primary hypercholesterolaemia (heterozygous familial and non-familial), mixed dyslipidaemia
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
Fluvastatin
: Primary hypercholesterolaemia, mixed dyslipidaemia
–
only
adults (18 years old or older)
Pemafibrate
: Dyslipidemia characterised by high TG ≥150 mg/dL
–
only
adults (18 years old or older)
Pitavastatin
: Primary hypercholesterolaemia, mixed dyslipidaemia
–
only
adults (18 years old or older)
Pravastatin
: Primary hypercholesterolaemia, mixed dyslipidaemia
–
only
adults (18 years old or older)
Rosuvastatin
: Primary hypercholesterolaemia, mixed dyslipidaemia
–
only
elderly (65 years old or older)
Simvastatin
: Primary hypercholesterolemia, mixed dyslipidaemia
–
only
adults (18 years old or older)
|
Dyssomnia | |
Dystrophic epidermolysis bullosa |
Beremagene geperpavec
: Dystrophic epidermolysis bullosa
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.